Stony Brook University Announces Collaboration with Sanofi on Pioneering Tuberculosis Drug
Thursday, January 19, 2012 - 10:00
in Health & Medicine
The Institute of Chemical Biology & Drug Discovery (ICB&DD) at Stony Brook University announced a multi-year research collaboration with Sanofi, a multinational pharmaceutical company, on a potential treatment for Tuberculosis (TB) and other bacterial infections.